tiprankstipranks
Neuphoria Therapeutics (NEUP)
NASDAQ:NEUP
US Market
NEUP
Neuphoria Therapeutics
RESEARCH TOOLSreports
Want to see NEUP full AI Analyst Report?

Neuphoria Therapeutics (NEUP) Income Statement

299 Followers

Neuphoria Therapeutics Income Statement

Last quarter (Q3 2026), Neuphoria Therapeutics's total revenue was AU$0.00, a decrease of -100.00% from the same quarter last year. In Q3, Neuphoria Therapeutics's net income was AU$-733.52K. See Neuphoria Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Jun 25Jun 24Jun 23Jun 22Jun 21
Total Revenue
AU$ 15.65MAU$ 0.00AU$ 0.00AU$ 263.61KAU$ 0.00
Gross Profit
AU$ 15.65MAU$ 0.00AU$ 0.00AU$ 263.61KAU$ 0.00
Operating Expenses
AU$ 16.78MAU$ 26.79MAU$ 33.09MAU$ 21.60MAU$ 8.96M
Depreciation and Amortization
AU$ 1.01MAU$ 992.56K-AU$ 1.11MAU$ 1.28M
EBITDA
AU$ -121.90KAU$ -25.65MAU$ -31.45MAU$ -20.81MAU$ -4.51M
Operating Income
AU$ -1.13MAU$ -26.79MAU$ -33.09MAU$ -21.34MAU$ -8.96M
Other Income/Expenses
AU$ 291.09KAU$ 3.46MAU$ 695.55K-AU$ 2.28M
Pretax Income
AU$ -838.00KAU$ -23.32MAU$ -32.39MAU$ -21.95MAU$ -6.68M
Net Income
AU$ -369.63KAU$ -23.19MAU$ -32.18MAU$ -21.76MAU$ -6.53M
Per Share Metrics
Basic EPS
AU$ -0.23AU$ -0.10AU$ -0.17AU$ -0.13AU$ -0.10
Diluted EPS
AU$ -0.23AU$ -0.10AU$ -0.17AU$ -0.13AU$ -0.10
Weighted Average Shares Outstanding
 1.62M 149.80M 122.39M 112.78M 65.00M
Weighted Average Shares Outstanding (Diluted)
 1.62M 149.80M 122.39M 112.78M 65.00M
Currency in AUD

Neuphoria Therapeutics Earnings and Revenue History